The call for papers is open:
Authors are invited to submit abstracts to be considered for the 8th European Conference on FASD.
All submissions must be made electronically via the submission form on the congress home page.
Please read the guidelines detailed below before proceeding with your submission.
• Abstract submission opens on Tuesday, September 16, 2025
• Abstract submission deadline: Monday, January 19, 2026, until 23:59h. (CET)
PLEASE NOTE
Abstracts on works already published by the time of the last EUFASD Conference (Sept. 2024) will not be considered, as well as those presented at a previous EUFASD conference.
All the proposals must be submitted in English. Please properly check English language and spelling before submission.
ABSTRACT FORMAT
Maximal length of 350 words, not including title and authors.
Title and authors must not be included in the text of the abstract. There are special text fields to include this information in the next page of the submission form.
One table, image or figure is allowed, optional, not exceeding 500ko but with sufficient resolution, not exceeding half a page (Arial 10 for table), complementing but not replacing the text of the abstract which must remain fully comprehensible without it.
A maximum of 10 authors can be listed, one place in the list can be for et alii/aliae.
ABSTRACT SUBMISSION PROCESS
All submissions must be made electronically via the submission system on the Conference home page.
When finishing the submission process, submitter/corresponding author should receive an acknowledgement
e-mail with a reference number. If not, please contact eufasd2026@ptolemee.com
Submitter author will be able to modify the abstract before the submission deadline through the online submission form. Access to previous submission will require the given email and the password received in the acknowledgement email after submission.
All submissions are subjected to a peer-review process to secure high quality.
A notification of acceptance or rejection will be only sent to the submitter (corresponding author). It is his/her responsibility to notify other authors. Notification to the authors is expected from …
If the abstract is accepted the presenting author needs to be registered on due date to confirm participation in the program and to attend the Conference to present the contribution. Otherwise, the contribution will be withdrawn from the Conference program.
TOPICS
Papers can cover a wide scope of topics:
1. Pathophysiology
2. Epidemiology
3. Prevention & harm reduction
4. Diagnoses
5. Brain, cognition & behaviors
(neurophenotype)
6. Prognosis
7. Interventions & care
8. Adulthood & lifelong burden
9. Empowerment & advocacy |
HIGHLIGHTS
Among these topics, special emphasis will be placed on:
a. key mechanisms of alcohol developmental toxicity
and susceptibility
b. cumulative vulnerabilities and comorbid risk factors
c. accuracy and reliability in epidemiological estimates
d. prevention and harm reduction in high-risk population
e. improving diagnosis of non-syndromic forms of FASD:
▪ etiological specificity and differential workup
▪ (bio)markers beyond facial feature and exposure report
f. neurodevelopmental disorders (NDDs) and FASD:
▪ brain and neurodevelopmental phenotype
▪ meaning and coordinate use of the different types
of diagnoses
g. evidence-basing for unspecific and
FASD-designed interventions
h. anticipation and prevention of secondary disabilities
and disorders
i. life paths, care paths, barriers and facilitators
j. expectations and challenges of new technologies
|
When submitting, the authors will be asked to qualify their paper into one of these categories:
• Preclinical & translational research
• Clinical trial & care expertise
• « Living with FASD »: people & community (caregivers, family...) perspectives
• « What happens in my country? »
Please indicate one of the major topics (1, 2, 3...) and, if possible, a highlight (a, b, c...).
SCHOLARSHIPS
A few scholarships will be awarded to make it easier for some who need to participate, for instance juniors.
Stay tuned for terms and conditions for application (to be published soon).
PRESENTATION PREFERENCE
When submitting, the authors will be asked to choose presentation-type preference:
1) Oral paper presentation (9 parallel sessions in 3 slots) :
9 min short oral communications + 3-4 min questions
2) Poster paper presentation (2 dedicated poster sessions) :
3 min live presentation + 1 question, at least 2 parallel chaired visit groups
(please note that) a few papers of particular interest regarding the conference program could be proposed with a longer plenary oral presentation by the scientific planning committee.
The final decision about the presentation format will be determined by the Scientific Committee after the reviewing process and this decision will be final.
FOR MORE INFORMATION
For all questions related to abstract submission, please contact eufasd2026@ptolemee.com |
